Search results
Author(s):
Moritake Iguchi
,
Hiromichi Wada
,
Felipe Martínez
,
et al
Added:
1 year ago
Author(s):
Byoung Geol Choi
,
Seung-Woon Rha
,
Se Yeon Choi
,
et al
Added:
9 months ago
Author(s):
Maki Komiyama
,
Moritake Iguchi
,
Hiromichi Wada
,
et al
Added:
10 months ago
Author(s):
Frederick Raal
Added:
1 year ago
ESC 23 — Prof Frederick Raal (University of the Witwatersrand, Johannesburg, SA) outlines the late-breaking results from the LIBerte-HeFH study (NCT04797104).
The phase III LIBerte-HeFH study (LIB Therapeutics LLC) aimed to assess the effectiveness of PCSK9-inhibitor Ierodalcibep (LIB003) in reducing low-density lipoprotein cholesterol (LDL-C) in 300mg doses administered subcutaneously in…
View more
Author(s):
Simran Singh Parmar
,
Vasantha Muthuppalaniappan
,
Debasish Banerjee
Added:
1 year ago
Author(s):
Massimiliano Camilli
,
Luca Maggio
,
Lorenzo Tinti
,
et al
Added:
1 month ago
Author(s):
Martin Berger
,
Nikolaus Marx
,
Katharina Marx-Schütt
Added:
1 month ago
Author(s):
Anastasia Shchendrygina
,
Ilya Giverts
,
Mariya Tokmakova
,
et al
Added:
6 months ago
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
8 months ago
ESC Congress 24 – Day 1 of the ESC Congress 2024 was filled with excitement as new clinical practice guidelines were unveiled, along with several highly anticipated Hot Line trials.Interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) are concluding the first day by providing practical summaries of the key guidelines and offering critical insights…
View more
Author(s):
Maria Lorenza Muiesan
Added:
1 month ago